ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating restated by analysts at Peel Hunt in a research note issued to investors on Monday, ThisIsMoney.Co.Uk reports.
Other research analysts have also recently issued reports about the company. Goldman Sachs Group increased their price target on ConvaTec Group from GBX 118 ($1.55) to GBX 183 ($2.41) and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Shore Capital cut ConvaTec Group to a “hold” rating in a research report on Thursday, January 23rd. Royal Bank of Canada cut ConvaTec Group to a “sector performer” rating and cut their price objective for the company from GBX 210 ($2.76) to GBX 197 ($2.59) in a research report on Monday, December 9th. Jefferies Financial Group raised their price objective on ConvaTec Group from GBX 220 ($2.89) to GBX 250 ($3.29) and gave the company a “buy” rating in a research report on Tuesday, January 21st. Finally, UBS Group reaffirmed a “buy” rating on shares of ConvaTec Group in a research report on Friday. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company. ConvaTec Group has a consensus rating of “Hold” and a consensus price target of GBX 202.36 ($2.66).
Shares of LON CTEC opened at GBX 215.80 ($2.84) on Monday. The stock has a 50 day moving average price of GBX 209.68 and a 200 day moving average price of GBX 191.25. ConvaTec Group has a 52 week low of GBX 113.25 ($1.49) and a 52 week high of GBX 225.80 ($2.97). The company has a debt-to-equity ratio of 104.76, a quick ratio of 1.58 and a current ratio of 2.37. The stock has a market capitalization of $4.28 billion and a PE ratio of 26.98.
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Further Reading: Initial Coin Offering (ICO)
Receive News & Ratings for ConvaTec Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ConvaTec Group and related companies with MarketBeat.com’s FREE daily email newsletter.